SEC Form 4 · accession 0001596771-17-000011
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Benjamin Wolin
Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 15, 2017 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 14, 2017 | A | 5,119 | $0.00 | A | 9,559 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of restricted stock were granted under the Issuer's non-employee director compensation program in connection with Mr. Wolin's appointment as independent Lead Director. The shares vest pro rata annually over two years, with 50% vesting on each of the first and second anniversaries of the grant date.